0001209191-19-000963.txt : 20190103 0001209191-19-000963.hdr.sgml : 20190103 20190103162811 ACCESSION NUMBER: 0001209191-19-000963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULME ALLISON CENTRAL INDEX KEY: 0001573886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36054 FILM NUMBER: 19505917 MAIL ADDRESS: STREET 1: C/O SOPHIRIS BIO INC., 1258 PROSPECT ST CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOPHIRIS BIO INC. CENTRAL INDEX KEY: 0001563855 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-777-1760 MAIL ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-31 0 0001563855 SOPHIRIS BIO INC. SPHS 0001573886 HULME ALLISON 1258 PROSPECT STREET LA JOLLA CA 92037 1 1 0 0 Chief Operating Officer Common Stock (Right to Buy) 0.83 2018-12-31 4 A 0 245000 0.00 A 2019-12-21 2028-12-30 Common Stock 245000 245000 D 33% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021. /s/ Peter Slover, Attorney-in-fact 2019-01-02